Kidney Transplantation

Nephrology·MeSH: Kidney Failure, Chronic

28 drugs in development·8 companies·8 clinical trials

Drug Pipeline by Phase

Phase 3(9)

Drug	Company
alemtuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
anti-cd20 antibodies	GT Biopharma, Inc. (GTBP)
anti-cd20 antibodies	POINT Biopharma Global Inc. (PNT)
belatacept	ENANTA PHARMACEUTICALS INC (ENTA)
belatacept	Cidara Therapeutics, Inc. (CDTX)
eculizumab	GT Biopharma, Inc. (GTBP)
eculizumab	POINT Biopharma Global Inc. (PNT)
ivig	GT Biopharma, Inc. (GTBP)
ivig	POINT Biopharma Global Inc. (PNT)

Phase 2(8)

Phase 1(11)

Drug	Company
alemtuzumab	Accustem Sciences Inc. (ACUT)
alemtuzumab	Cidara Therapeutics, Inc. (CDTX)
belatacept	Accustem Sciences Inc. (ACUT)
Donor-derived Mesenchymal Stromal Cells	Cidara Therapeutics, Inc. (CDTX)
Donor-derived Mesenchymal Stromal Cells	Accustem Sciences Inc. (ACUT)
mycophenolate acid	Accustem Sciences Inc. (ACUT)
mycophenolate mofetil	Accustem Sciences Inc. (ACUT)
mycophenolate mofetil	ENANTA PHARMACEUTICALS INC (ENTA)
mycophenolate mofetil	Cidara Therapeutics, Inc. (CDTX)
sirolimus	Cidara Therapeutics, Inc. (CDTX)
sirolimus	Accustem Sciences Inc. (ACUT)

BioSniper tracks 28 drugs in development for Kidney Transplantation across 8 companies.

There are 8 clinical trials targeting Kidney Transplantation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.